Contract analysis
Clause-by-clause risk read on any document of the firm. Pick a contract, or open any document from a matter.
Contract analysis / post-closing-obligations-tracker.xlsx
post-closing-obligations-tracker.xlsx
High · 1
Medium · 0
Standard · 0
[sheet: Summary]
High
⚑ Indemnity / guarantee obligation
[sheet: Summary] Field | Value Matter | Penterra Pharmaceuticals Corp. — Out-License of PPC-4187 (Penteracitinib) to Meridian Bio Therapeutics Ltd. Compound | PPC-4187 (Penteracitinib); Selective JAK1 Inhibitor; 25 mg and 50 mg film-coated tablets Proposed Trade Name | PENTECLAR Licensor | Penterra Pharmaceuticals Corp. (Delaware corporation; Nasdaq: PNTR) Licensor Address | 400 Pharma Drive, Suite 800, Princeton, NJ